Ticker
ALVIO
Analysis
Valerio Therapeutics (ALVIO) Stock Analysis
Valerio Therapeutics investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to ALVIO.
Valerio Therapeutics
Valerio Therapeutics investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to ALVIO.
Stock profile
Asset type
Stock
Market cap
$119.4M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Currency
EUR
Ticker listings
Valerio Therapeutics may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- ALVIO primary listing
- A0HMXA
- 0NWK
- C4X
- ALVIOP
Latest Valerio Therapeutics news
Valerio Therapeutics Announces Binding Term-Sheet for Collaboration and Exclusive License With Seed-Stage Biotech Company
VILLEJUIF, France, May 18, 2026--Regulatory News: Valerio Therapeutics (FR0010095596 – ALVIO), a biotechnology company specializing in the development of technology platforms de...
Valerio Therapeutics Announces the Launch of InVimmune, a New Company Dedicated to Developing Differentiated in Vivo Cell Therapy Approaches
VILLEJUIF, France, May 04, 2026--Regulatory News: Valerio Therapeutics (FR0010095596 – ALVIO), a biotechnology company specializing in the development of technology platforms de...
Valerio Therapeutics Publishes Its 2025 Annual Results and Annual Financial Report, and Confirms the Strategic Transformation of Its Oper...
VILLEJUIF, France, April 29, 2026--Regulatory News: Valerio Therapeutics (FR0010095596 – ALVIO), a biotechnology company specializing in the development of technology platforms ...
Valerio Therapeutics : publishes its 2025 annual results and annual financial report, and confirms the strategic transformation of its op...
Valerio Therapeutics : publishes its 2025 annual results and annual financial report, and confirms the strategic transformation of its operating
Valerio Therapeutics Announces the Appointment of Professor Eric Vivier as Observer to Its Board of Directors
PARIS, December 17, 2025--Regulatory News: Valerio Therapeutics ("Valerio Therapeutics" or the "Company") (Euronext Growth Paris: ALVIO) announces the appointment of Professor E...
Research sections
Valuation
Review valuation context for Valerio Therapeutics.
Future growth
Review future growth context for Valerio Therapeutics.
Past performance
Review past performance context for Valerio Therapeutics.
Financial health
Review financial health context for Valerio Therapeutics.
Dividend
Review dividend context for Valerio Therapeutics.
Management
Review management context for Valerio Therapeutics.
Ownership
Review ownership context for Valerio Therapeutics.
Other information
Review other information context for Valerio Therapeutics.
Community
Review community context for Valerio Therapeutics.